n(1)-acetylphenylhydrazine has been researched along with Thalassemias in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agostoni, A; Beretta, L; Bianchi, M; Gerli, GC; Gualandri, V; Orsini, GB | 1 |
| Lachant, NA; Tanaka, KR | 1 |
1 trial(s) available for n(1)-acetylphenylhydrazine and Thalassemias
| Article | Year |
|---|---|
Antioxidants in sickle cell disease: the in vitro effects of ascorbic acid.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Anemia, Sickle Cell; Antioxidants; Ascorbic Acid; Clinical Trials as Topic; Drug Evaluation; Erythrocytes; Erythrocytes, Abnormal; Heinz Bodies; Humans; In Vitro Techniques; Pentose Phosphate Pathway; Phenylhydrazines; Reticulocytes; Thalassemia; Tiopronin; Vitamin E; Vitamin E Deficiency | 1986 |
1 other study(ies) available for n(1)-acetylphenylhydrazine and Thalassemias
| Article | Year |
|---|---|
Erythrocyte superoxide dismutase, catalase and glutathione peroxidase in glucose-6-phosphate dehydrogenase deficiency.
Topics: Adolescent; Adult; Catalase; Child; Erythrocytes; Female; Glucosephosphate Dehydrogenase Deficiency; Glutathione Peroxidase; Humans; Male; Phenylhydrazines; Superoxide Dismutase; Thalassemia; White People | 1982 |